Skip to main content
Clinical Trials/NL-OMON54229
NL-OMON54229
Not yet recruiting
Not Applicable

Defining optimal imaging strategies for diagnosis, treatment, and treatment evaluation of chordomas and chondrosarcomas of the axial skeleton - Optimization of chordoma and chondrosarcoma proton therapy

eids Universitair Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bone tumor
Sponsor
eids Universitair Medisch Centrum
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria: referred to HPTC, or LUMC, or the Netherlands
  • Committee of Bone tumors, histologically diagnosed with primary or recurrent
  • chordoma or chondrosarcoma in the axial skeleton (clivus, spine and sacrum),
  • and accepted for standard proton beam therapy.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • \- Diagnosis other than chordoma or chondrosarcoma is made.
  • \- Patient refuses (parts) of the standard treatment protocol.
  • \- Patient refuses MRI due to claustrophobia.
  • \- Patient not suitable for MRI due to the presence of MRI incompatible implants.
  • \- Incapacitated patients.
  • \- Patient doesn\*t allow coded data to be used for analysis.
  • \- Patient is under 18 years of age.
  • \- Lesion size less than 1cm.

Outcomes

Primary Outcomes

Not specified

Similar Trials